Office deals: Swiss biopharma firm lands in Brickell as French ag processor exits for Coral Gables

A Swiss biopharmaceutical company will establish its U.S. headquarters in Miami’s Brickell, while a French agricultural firm is leaving the financial district for Coral Gables.  Zug-based MoonLake Immunotherapeutics, which focuses on developing nanobody-based therapies for inflammatory skin and joint diseases, leased 13,500 square feet at Brickell Key Centre II, at 601 Brickell Key Drive, under a roughly 11-year term, according to the South Florida Business Journal.  Meanwhile, Sucden Americas — part of Paris-based Sucden, a sugar, cocoa, coffee and other agricultural products process and delivery company —  leased 7,700 square feet at 255 Alhambra Circle in Coral Gables under a […]

This article originally appeared on The Real Deal. Click here to read the full story.